Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
BMC Pediatrics|August 6, 2021
New onset ANCA-associated vasculitis in an adolescent during an acute COVID-19 infection: a case reportDaniel D Reiff, Chloe G Meyer, Brittany Marlin, et al.
Pediatric Rheumatology Online Journal|February 25, 2021
Distinguishing active pediatric COVID-19 pneumonia from MIS-CDaniel D Reiff, Melissa L Mannion, Nichole Samuy, et al.
Pulmonary Pharmacology|August 1, 1994
Comparison of the effect of inhaled selective and non-selective adrenergic agonists on cardiorespiratory parameters in chronic stable asthmaA J Williams, C Weiner, D Reiff, et al.
Life (Basel, Switzerland)|February 25, 2022
A Rare STXBP2 Mutation in Severe COVID-19 and Secondary Cytokine Storm SyndromeDaniel D Reiff, Mingce Zhang, Emily A Smitherman, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2024
PD-L1 expression is mediated by microRNA processing, Wnt/β-catenin signaling, and chemotherapy in Wilms tumorKavita Desai, Patricia D B Tiburcio, Austin Warne, et al.
Molecular Pharmacology|February 28, 2013
Probing the metabotropic glutamate receptor 5 (mGlu₅) positive allosteric modulator (PAM) binding pocket: discovery of point mutations that engender a "molecular switch" in PAM pharmacologyKaren J Gregory, Elizabeth D Nguyen, Sean D Reiff, et al.
Pediatric Blood & Cancer|June 13, 2025
PD-L1 Expression is Mediated by microRNA Processing, Wnt/β-Catenin Signaling, and Chemotherapy in Wilms TumorPatricia D B Tiburcio, Kavita Desai, Austin Warne, et al.
Pediatric Rheumatology Online Journal|October 14, 2023
Majority of new patient referrals to a large pediatric rheumatology center result in non-rheumatic diagnosisDaniel D Reiff, John M Bridges, Eileen C Rife, et al.
Blood|July 19, 2018
Noncovalent inhibition of C481S Bruton tyrosine kinase by GDC-0853: a new treatment strategy for ibrutinib-resistant CLLSean D Reiff, Elizabeth M Muhowski, Daphne Guinn, et al.
Cancer Discovery|November 6, 2023
First-in-Human Study of the Reversible BTK Inhibitor Nemtabrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia and B-Cell Non-Hodgkin LymphomaJennifer A Woyach, Deborah M Stephens, Ian W Flinn, et al.
Pageof 3